Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00615_DB01142_nanopub.RAz6c0akVgMrK6atGT8Nh3W2cR-VBnxvNqsSxIinMS9UY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00615_DB01142 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00615_DB01142 label "DDI between Rifabutin and Doxepin - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, doxepin, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if rifabutin is initiated, discontinued or dose changed. [drugbank_resource:DB00615_DB01142]" assertion.
- drugbank_resource:DB00615_DB01142 identifier "drugbank_resource:DB00615_DB01142" assertion.
- drugbank_resource:DB00615_DB01142 title "DDI between Rifabutin and Doxepin - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, doxepin, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if rifabutin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00615 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00615_DB01142 assertion.
- drugbank:DB01142 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00615_DB01142 assertion.